- €691.77m
- €756.08m
- €305.73m
- 81
- 35
- 58
- 60
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 290 | 273 | 326 | 348 | 306 |
Cost of Revenue | |||||
Gross Profit | 167 | 165 | 190 | 202 | 177 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 248 | 228 | 277 | 296 | 264 |
Operating Profit | 42.5 | 44.8 | 49.2 | 52.2 | 41.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40.7 | 42.9 | 48.2 | 51.3 | 37.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.5 | 31.6 | 37.1 | 41.1 | 28.8 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 28.3 | 31.5 | 37.1 | 41.2 | 28.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.3 | 31.5 | 37.1 | 41.2 | 28.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.479 | 0.505 | 0.635 | 0.669 | 0.46 |
Dividends per Share |